World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00692328
Date of registration: 04/06/2008
Primary sponsor: Oregon Health and Science University
Public title: Expectation and Response to Levodopa and Acupuncture in Parkinson's Disease
Scientific title: Expectation and Response to Levodopa & Acupuncture in Parkinson's Disease
Date of first enrolment: August 2005
Target sample size: 63
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00692328
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science  
Countries of recruitment
United States
Contacts
Name:   Jou-Shin Lou, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Oregon Health and Science University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Clinical diagnosis of Parkinson's disease

- Able to withdraw Parkinson's disease medication for 12 hours prior to a study visit

- Must be currently using levodopa to qualify for the levodopa part of the study

Exclusion Criteria:

- History of seizures

- Presence of any metal in the body, including DBS stimulators, pacemakers, metal
plates or pins

- Severe cognitive deficits or psychosis

- Evidence of any clinically unstable disease, such as cancer, HIV/AIDS; unstable heart
condition or other conditions that might require hospitalization

- Evidence of another neurological disease, such as multiple sclerosis, amyotrophic
lateral sclerosis, or Huntington's disease



Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Parkinson's Disease
Intervention(s)
Behavioral: Levodopa or acupuncture
Primary Outcome(s)
Fatigue rate and muscle response evoked by transcranial muscle stimulation (TMS) [Time Frame: Before and immediately after the intervention]
Secondary Outcome(s)
Secondary ID(s)
AT002656-02
U19 AT002656-02
U19AT002656-02
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Center for Complementary and Alternative Medicine (NCCAM)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history